Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Labcyte and Deerac Fluidics Combine Forces to Enhance Low Volume Liquid Handling

Published: Wednesday, January 30, 2008
Last Updated: Wednesday, January 30, 2008
Bookmark and Share
Labcyte and Allegro Technologies Limited have reached agreement on the terms for combination of the two companies.

Labcyte Inc. and Allegro Technologies Limited, which conducts business as Deerac Fluidics, announced that they have reached agreement on the terms for combination of the two companies. Completion of the transaction requires shareholder approval and is expected within one month.

As pharmaceutical companies, genomic service providers, and other life science research organizations desire to perform larger numbers of assays within fixed budgets, there is a strong drive to reduce the volume of each assay in order to reduce cost and minimize waste.

According to both companies, although products from both Labcyte and Deerac address the growing market of low-volume liquid handling, each company utilizes a unique technology and they operate in different volume ranges. Products from Labcyte and Deerac are used for different applications. They may also be used together when one component of an assay is added in the low nanoliter range and others are added in larger amounts.

The Deerac products are based on a patented feed-back controlled system which effective in the 50 nanoliter to 20 microliter range. This technology was conceived at Trinity College Dublin, and its development was supported by grants from Enterprise Ireland.

The Labcyte Echo ® liquid handlers use acoustic energy to transfer 2.5 nanoliter droplets and are most useful in the 2.5 to 200 nanoliter range.

“At Labcyte, we evaluated a wide variety of low-volume liquid handlers and found the Deerac Latitude™ and Equator™ to have the best precision in the 50 nanoliter range. We also found that the speed and flexibility of the Latitude could double the throughput of our new POD™ 810 plate assembler for assay plate preparation. The two teams have also conducted several joint seminars on low-volume assays and our people work well together,” said Dr. Elaine J. Heron, Chief Executive Officer of Labcyte. “It became clear that it made sense to combine the two companies.”

“Having research and manufacturing groups in Dublin gives us a solid base from which to support our growing business in Europe,” continued Dr. Heron. “Dublin offers a vibrant research community with business-friendly policies. The innovative atmosphere created by Trinity College Dublin makes location of our European operations close by especially attractive.”

“We are excited to become part of the business that has brought acoustic droplet ejection from a concept to a mainstream product used by most pharmaceutical companies,” said Dr. Jurgen Osing, the Managing Director of Deerac Fluidics, “and we are anxious to use our expertise in genomics to expand the applications of Labcyte Echo systems. This is also an opportunity for providing more local support for the Latitude and Equator products.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Sanger Institute, St Jude Data-Sharing Agreement
Childhood cancer targeted by Sanger Institute and St Jude Children’s Research Hospital exchanges of cancer data
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Space Research Fighting Cancer
JPL and National Cancer Institute renew Big Data partnership that 'learns' data similarities.
Uncovering the Genetics Behind High Blood Pressure
Results suggest a role for blood vessels themselves in controlling blood pressure.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!